August 8th, 2018: Understanding and Remembrance Day for Severe ME
Have you heard of our Severe Myalgic Encephalomyelitis Day of Understanding and Remembrance? Please join Jody Smith in observing this day and honoring the 25% of those with ME/CFS who are most severely ill.
Discuss the article on the Forums.

Increased intestinal permeability may allow HIV to cross BBB

Discussion in 'Other Health News and Research' started by guest, Jan 20, 2010.

  1. guest

    guest Guest


    In up to 20 percent of people infected with HIV, the virus manages to
    escape from the bloodstream and cross into the brain, resulting in HIV-
    associated dementia and other cognitive disorders. Now, scientists at
    the Albert Einstein College of Medicine of Yeshiva University have
    found strong evidence that a component of the cell walls of intestinal
    bacteria - a chemical present in high levels in the blood of HIV-
    infected people - helps HIV to penetrate the usuallyimpregnable blood
    brain barrier (BBB). The findings, published in the August issue of
    the Journal of Virology, could lead to strategies for preventing HIV
    from entering the brain and causing serious complications.

    "Previous research has suggested that it's not individual HIV viruses
    that get into the brain but rather HIV-infected immune cells known as
    monocytes," says Dr. Harris Goldstein, director of the Einstein-
    Montefiore Medical Center for AIDS Research and senior author of the
    study. "Using an animal model, we wanted to find out first of all
    whether being infected with HIV enables monocytes to do what they
    don't usually do - escape from blood vessels and enter brain tissue."

    Overcoming HIV's inability to infect mice, Dr. Goldstein and his
    colleagues had previously created a transgenic mouse line, HIV-TG
    mice, equipped with all the genes needed to make HIV - and that
    produces HIV in those cells, including monocytes and T cells, in which
    the virus multiplies in people. The HIV-TG mice were then bred with
    another transgenic mouse line, GFP-TG mice, containing the gene that
    codes for green fluorescent protein (GFP). The result: a double
    transgenic mouse line, HIV/GFP-TG mice, whose HIV-infected monocytes
    carried the GFP gene. This meant that the monocytes could be detected
    - either by looking for glowing green cells under the microscope or by
    using polymerase chain reaction, a sensitive genetic assay capable of
    detecting the DNA of the GFP gene.

    Next, the researchers isolated millions of monocytes - HIV/GFP-
    producing monocytes from the HIV/GFP-TG mice, and monocytes from the
    GFP-TG mice producing GFP alone - and injected each type of monocyte
    into control mice.

    Four days later, the researchers examined the brains of the injected
    mice to see whether monocytes from the bloodstream had crossed their
    BBB's. While there was no sign of monocytes in the brains of any of
    the mice injected with uninfected GFP monocytes, ultrasensitive DNA
    analysis showed that HIV/GFP monocytes were present at very low levels
    in the brains of nearly one third of the mice injected with the HIV-
    producing monocytes. "These results demonstrated very clearly that
    being infected with HIV somehow gives monocytes the capacity to cross
    an intact BBB," says Dr. Goldstein. "But we also suspected that
    something else was making it easier for HIV-infected monocytes to
    breach the defenses protecting the brain from infection."

    In 2006, scientists at the National Institutes of Health had reported
    that HIV infection breaks down barriers in the intestine that normally
    prevent intestinal bacteria from entering the bloodstream. The blood
    of HIV-infected people was found to contain markedly elevated levels
    of lipopolysaccharide (LPS), a component of certain bacteria that are
    normally confined to the intestine but leak out due to HIV infection.
    In addition, previous animal studies had shown that exposure to
    elevated LPS levels compromised the integrity of the BBB. "So we
    hypothesized that the combination of HIV-infected monocytes and
    elevated LPS levels would amplify the ability of HIV to cross the BBB
    and get into the brain," says Dr. Goldstein. To test this hypothesis,
    his team injected control mice with very low doses of LPS that were
    comparable to the levels in the bloodstream of HIV-infected
    individuals and would only minimally weaken their BBB's. Three hours
    later, half the mice were intravenously injected with HIV-and-GFP-
    producing monocytes, while the remaining mice were intravenously
    injected with GFP-producing monocytes that were otherwise normal.

    Four days later, monocytes could not be detected in the brains of any
    of the 15 mice that were pretreated with LPS and then injected with
    normal monocytes producing GFP alone. By contrast, monocytes were
    readily detected in the brains of about 25% of mice pre-treated with
    LPS and then injected with HIVand- GFP-producing monocytes.

    "Clearly, HIV-infected monocytes uniquely benefit from the LPS that is
    present in high amounts in the blood of HIV-infected people," says Dr.
    Goldstein. "So when HIV-infected monocytes are 'knocking on the door'
    of the BBB and starting to crack it open, the LPS facilitates their
    entry by making the BBB more permeable, apparently by weakening blood
    vessel structure."

    If HIV-infected monocytes and LPS in the bloodstream can be considered
    a one-two punch for entry into the brain, a third punch - simply
    having a systemic HIV infection - also seems to help soften up the
    BBB. In making this discovery, Dr. Goldstein used his HIV-TG mouse
    strain, in which HIV is known to replicate inside brain cells
    associated with the BBB. These HIV-TG mice, along with control mice,
    were injected with LPS and, three hours later, intravenously injected
    with HIV-and-GFP-producing monocytes from the HIV/GFP-TG mouse

    Four days later, HIV-producing monocytes could be detected in the
    brains of about 25 percent of the control mice, as in the preceding
    experiment. By contrast, more than twice as many (70 percent) of the
    brains of HIV-TG mice that support systemic HIV infection contained
    HIV-producing monocytes. Even more impressive: When present, HIV-
    producing monocytes were three times more numerous in the brains of
    HIV-TG mice than in the brains of control mice.

    "These results demonstrate very dramatically that HIV infection of
    cells associated with the BBB, in conjunction with LPS exposure,
    contributes to BBB breakdown," says Dr. Goldstein. (See slides below).
    "So when HIV infection occurs, we seem to have a 1-2-3 combination of
    punches working in concert to facilitate entry of HIV-infected
    monocytes into the BBB-protected brain: HIV infection of monocytes
    increases their capacity to cross even an intact BBB; HIV infection in
    the gut releases LPS into the bloodstream allowing it to erode the
    BBB; and HIV infection of the cells of the BBB makes them more
    sensitive to the deleterious effects of LPS."

    These findings could lead to preventive or therapeutic strategies. To
    help maintain the integrity of the BBB in HIV-infected people, says
    Dr. Goldstein, one approach might be to monitor the LPS level in their
    bloodstream and then reduce elevated levels. "We may be able to use
    antibiotics that kill intestinal bacteria that make LPS, and drugs are
    already available that can bind to LPS and clear it from the
    bloodstream," says Dr. Goldstein. "Ideally, we would promptly start
    newly diagnosed HIV-infected patients on a treatment to reinforce
    their BBB's so that HIV can't penetrate it - and perhaps we could even
    strengthen the BBB's of people who've been infected for quite a while.
    But before we can prevent the tragedy of HIV-associated dementia, we
    need to better understand the mechanism by which these molecular and
    cellular 'punches' interact to undermine the BBB."

    Other Einstein researchers involved in the study were Drs. Hongwei
    Wang and Jinglin Sun.
  2. Frank

    Frank Senior Member

    I can't emphasize it enough, healing your gut, means feeling better!

See more popular forum discussions.

Share This Page